Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Fuji
AstraZeneca
Boehringer Ingelheim
Farmers Insurance
Cantor Fitzgerald
Express Scripts
Dow
Federal Trade Commission

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077621

« Back to Dashboard

NDA 077621 describes AZATHIOPRINE, which is a drug marketed by Amneal Pharms Llc, Mylan, Zydus Pharms Usa, and West-ward Pharms Int, and is included in four NDAs. It is available from fourteen suppliers. Additional details are available on the AZATHIOPRINE profile page.

The generic ingredient in AZATHIOPRINE is azathioprine sodium. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the azathioprine sodium profile page.
Summary for 077621
Tradename:AZATHIOPRINE
Applicant:Zydus Pharms Usa
Ingredient:azathioprine
Patents:0
Therapeutic Class:Immunological Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 077621
Suppliers and Packaging for NDA: 077621
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AZATHIOPRINE azathioprine TABLET;ORAL 077621 ANDA Rebel Distributors Corp.. 21695-484 21695-484-75 75 TABLET in 1 BOTTLE (21695-484-75)
AZATHIOPRINE azathioprine TABLET;ORAL 077621 ANDA Aidarex Pharmaceuticals LLC 33261-758 33261-758-75 75 TABLET in 1 BOTTLE (33261-758-75)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Mar 15, 2007TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Sep 5, 2008TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength75MG
Approval Date:Sep 5, 2008TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
QuintilesIMS
Harvard Business School
Medtronic
Queensland Health
Colorcon
McKesson
Accenture
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot